Matrix Surgical USA

Matrix Surgical USA, established in 2012, is a privately held company headquartered in Atlanta, Georgia. Their flagship product, OMNIPORE® Surgical Implants, is a biocompatible form of porous High-Density Polyethylene utilized for the reconstruction or augmentation of the craniomaxillofacial skeleton. With a product range encompassing over 80 unique SKUs in various anatomical configurations, the company serves healthcare providers in the United States and through a global network of stocking distributors across 35 countries. Despite lacking specific details on the latest investment, Matrix Surgical USA presents an intriguing prospect for investors due to its innovative product range, global market presence, and commitment to addressing critical medical needs within the manufacturing sector. Their comprehensive portfolio and international reach position them as an attractive opportunity for potential venture capital consideration. The company's emphasis on biocompatibility and diverse product line solidifies its potential for growth and impact within the medical industry.